Global Kidney Academy(@GKA_CME) 's Twitter Profileg
Global Kidney Academy

@GKA_CME

The Global Kidney Academy (GKA) is an educational program for physicians and other healthcare professionals involved in nephrology.

ID:1592955364617736192

linkhttps://globalkidneyacademy.org/learningcenter calendar_today16-11-2022 18:59:01

177 Tweets

607 Followers

700 Following

Global Kidney Academy(@GKA_CME) 's Twitter Profile Photo

In this activity, we’re examining quality of life for patients with chronic kidney disease-associated pruritus by taking an in-depth look at real-world patient cases: ow.ly/c4Ta50Rflee

In this #CME activity, we’re examining quality of life for patients with chronic kidney disease-associated pruritus by taking an in-depth look at real-world patient cases: ow.ly/c4Ta50Rflee #MedEd #MedTwitter #CKD #kidneydisease
account_circle
Global Kidney Academy(@GKA_CME) 's Twitter Profile Photo

goes unnoticed in many patients, despite affecting an estimated 13% of the US population. Explore the implications of unrecognized CKD and the importance of early diagnosis with nurse Ashley Baker and Dr. Chi D. Chu: bit.ly/4ann2sM Chi Chu

account_circle
Global Kidney Academy(@GKA_CME) 's Twitter Profile Photo

Inform your clinical practice by exploring this systematic review and meta-analysis of available treatment modalities and outcomes of in patients with , including end-stage renal disease: bit.ly/3ZYqzaM

account_circle
Global Kidney Academy(@GKA_CME) 's Twitter Profile Photo

In this activity focused on HFrEF and CKD, we’re breaking down how to identify the barriers to optimal treatment in patients on hemodialysis and discussing the real-world evidence on using potassium-lowering agents in challenging patient groups: bit.ly/3vDjrYq

account_circle
Global Kidney Academy(@GKA_CME) 's Twitter Profile Photo

AAVs affect multiple organs and are treated with glucocorticoids, immunosuppressants, and targeted biological medications. New classification criteria incorporating newer tests and novel imaging techniques are coming. Here's what you need to know: ow.ly/syy550QMzJz

account_circle
Global Kidney Academy(@GKA_CME) 's Twitter Profile Photo

In a phase 3 trial, researchers enrolled select patients who were randomly assigned to receive sparsentan or irbesartan (active control) for 108 weeks. Explore their findings now: ow.ly/EfSe50QMzFY

account_circle
Global Kidney Academy(@GKA_CME) 's Twitter Profile Photo

How can we manage in patients with and ? We’re discussing key data from clinical trials focused on the efficacy of currently available potassium binders in this free activity: ow.ly/7FvG50QMzEL

Ellie Kelepouris MD

How can we manage #hyperkalemia in patients with #CKD and #heartfailure? We’re discussing key data from clinical trials focused on the efficacy of currently available potassium binders in this free #CME activity: ow.ly/7FvG50QMzEL #MedTwitter #AskRenal @md_ellie
account_circle
Global Kidney Academy(@GKA_CME) 's Twitter Profile Photo

Check out this free activity to examine key data on care strategies for patients with IgA nephropathy. Experts are assessing various emerging therapies to optimize IgAN care here: ow.ly/uAT150QMzBQ

Check out this free #CME activity to examine key data on care strategies for patients with IgA nephropathy. Experts are assessing various emerging therapies to optimize IgAN care here: ow.ly/uAT150QMzBQ #nephrology #IgAnephropathy #AskRenal
account_circle
KDIGO(@goKDIGO) 's Twitter Profile Photo

Check out the March issue of KDIGO Direct for the latest news and updates from KDIGO: kdigo.co/KDIGO-Direct-M…

In this issue: KDIGO pays tribute to Tess Harris, the KDIGO 2024 CKD Guideline and World Kidney Day, a new Radcliffe Cardiology-KDIGO webinar: An Expert Approach to

Check out the March issue of KDIGO Direct for the latest news and updates from KDIGO: kdigo.co/KDIGO-Direct-M… In this issue: KDIGO pays tribute to Tess Harris, the KDIGO 2024 CKD Guideline and World Kidney Day, a new Radcliffe Cardiology-KDIGO webinar: An Expert Approach to
account_circle